Lilly Cancer Drug Receives FDA Approval
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says the U.S. Food and Drug Administration has approved Verzenio in combination with endocrine therapy for the treatment of certain early-stage breast... Read More